Celltrion Goes It Alone With First Solo US Biosimilar Launch

Vegzelma Is The Fourth FDA-Approved Bevacizumab Rival To Avastin

 
• By David Wallace
  
Celltrion_Magnified
Celltrion is striking out on its own with the launch of Vegzelma
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products